Orion Biotechnology Canada Ltd. — Form D

Orion Biotechnology Canada Ltd. of OTTAWA, ONTARIO, Z4, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-09. $605K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Mark Sheila GroperDirectorOttawa, A6
Anatolii Sheila KlepatskyiDirectorGeneva, V8
Rudolf BomExecutive OfficerOttawa, A6
Mark Sheila GroperExecutive OfficerOttawa, A6
Thomas Sheila HechtExecutive OfficerOttawa, A6
Anatolii Sheila KlepatskyiExecutive OfficerGeneva, V8
Theresa FirestoneDirectorToronto, A6
Theresa FirestoneExecutive OfficerToronto, A6
John JussupExecutive OfficerOttawa, Ontario, Z4
Lonnel CoatsDirectorOttawa, A6
Anatolii KlepatskyDirectorOttawa, Ontario, Z4
Anatolii KlepatskyExecutive OfficerOttawa, Ontario, Z4
Jean ForcioneDirectorOttawa, Ontario, Z4
Katie HewittDirectorOttawa, A6
Praveen TyleDirectorEncinitas, CA
Praveen TyleExecutive OfficerEncinitas, CA
Bradford SmithDirectorOttawa, Ontario, Z4
Mark GroperDirectorOttawa, Ontario, Z4
Mark GroperExecutive OfficerOttawa, Ontario, Z4
Jason BurkeExecutive OfficerOttawa, Ontario, Z4
Jason William BurkeExecutive OfficerOttawa, A6
Jean William ForcioneExecutive OfficerOttawa, A6
John William JussupExecutive OfficerOttawa, A6
Anatolii KlepatskyiDirectorOttawa, A6
Mark HechtDirectorOttawa, A6

Other filings by this issuer (5)

FiledFormOfferingSold
2025-08-26D/A$15.0M$6.8M
2024-07-23D$5.0M$743K
2023-03-15D/A$15.0M$9.9M
2021-06-22D/A$15.0M$5.4M
2021-06-15D$15.0M$5.4M

More